Study type

Study topic

Human medicinal product

Study type

Non-interventional study

Scope of the study

Safety study (incl. comparative)

Data collection methods

Secondary use of data
Non-interventional study

Non-interventional study design

Cluster design
Cohort
Other

Non-interventional study design, other

Non-randomised cluster design
Study drug and medical condition

Name of medicine

HEPLISAV B

Study drug International non-proprietary name (INN) or common name

HEPATITIS B SURFACE ANTIGEN

Anatomical Therapeutic Chemical (ATC) code

(J07BC01) hepatitis B, purified antigen
hepatitis B, purified antigen

Medical condition to be studied

Hepatitis B
Population studied

Age groups

Adults (18 to < 65 years)

Special population of interest

Pregnant women

Estimated number of subjects

206